inbios产品代理
inbios产品代理
传染病的创新诊断
InBios 是一家领先的生物技术公司，总部位于美国华盛顿州西雅图市。在 InBios，我们相信准确的诊断是有效治疗的第一步。我们专注于传染病和生物威胁免疫诊断设备的设计、开发和制造，致力于通过提供准确、易于使用且具有成本效益的优质产品来改善全球健康状况。
我们的专职员工中有专家。我们的科学家和工程师团队在开发和制造体外诊断测试方面拥有多年经验，并在传染病领域拥有额外的专业知识。我们招募了一支多元化、训练有素且受过高等教育的敬业专业人员团队，这使我们能够为您提供可靠且实用的解决方案，以应对具有挑战性的传染病诊断。
InBios 拥有悠久的市场领导地位。自 1996 年成立以来，InBios 已成功开发专有技术，用于为世界上最具破坏性的传染病创建快速和基于 ELISA 的免疫诊断分析。凭借在成功驾驭监管途径方面的丰富经验，我们拥有经 FDA 批准的寨卡病毒、登革热和西尼罗河 ELISA 试剂盒以及南美锥虫病和利什曼病的快速检测试剂盒。最近，我们应对了冠状病毒危机，收到了 FDA 对三种 COVID-19 产品的 EUA，同时继续开发其他测试来对抗这种流行病。 InBios 还专门开发和制造用于传染病研究的高度特异性和充分表征的抗体和抗原。
质量是我们成功的关键。质量至关重要，所有 InBios 产品均在美国根据严格的质量控制和性能验证程序制造。 InBios 符合 GMP、FDA 注册、美国农业部许可和 ISO 13485:2016认证。根据 EC IVD 指令 98/79/EC，大多数产品都带有 CE 标志。
我们的服务可帮助您开展业务。 InBios 是一家整体解决方案公司，在产品管道的各个方面拥有专业知识，从发现到应用。从概念到临床，InBios 与私营公司、联邦实验室和学术界合作，为我们的客户提供满足其诊断需求的最佳科学解决方案。在我们继续开发新产品以补充我们现有产品范围的同时，我们还可以协助您进行检测开发或合同制造服务
InBios International, Inc.
Innovative Diagnostics for Infectious Diseases
InBios is a leading biotechnology company based in Seattle, Washington (USA). At InBios, we believe an accurate diagnosis is the first step to effective treatment. Specializing in the design, development and manufacture of immunodiagnostic devices for infectious diseases and biothreats, we strive to improve health outcomes globally by providing superior quality products that are accurate, easy to use and cost effective.
We have experts on our dedicated staff. Our team of scientists and engineers have years of experience in developing and manufacturing in vitro diagnostic tests, with additional expertise in the field of infectious diseases. We have recruited a diverse, well-trained and highly educated group of dedicated professionals, which enables us to bring you reliable and practical solutions for challenging infectious disease diagnoses.
InBios has a long history of market leadership. Since our founding in 1996, InBios has successfully developed proprietary technologies used to create rapid and ELISA based immunodiagnostic assays for the world’s most devastating infectious diseases. With broad experience in successfully navigating regulatory pathways, we have FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. Most recently, we responded to the coronavirus crisis, receiving FDA EUAs for three COVID-19 products while continuing to develop other tests to fight this pandemic. InBios also specializes in the development and manufacture of highly specific and well-characterized antibodies and antigens for use in infectious disease research.
Quality is key to our success. With quality of utmost importance, all InBios products are manufactured in the United States under rigorous quality control and performance validation procedures. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified. Most products are CE Marked according to EC IVD Directive 98/79/EC.
Our services help you with your business. InBios is a total solution company with expertise in all facets of the product pipeline, from discovery to application. From concept to clinic, InBios partners with private companies, federal laboratories and academia to bring our customers the best scientific
solutions for their diagnostic needs. While we continue to develop new products to complement our existing product range, we can also assist you with assay development or contract manufacturing services.
